Skip to main content
Autobound logo

Regeneron news and events in 2026

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and...

Public (REGN)Biotechnology Research10,000+ employeesregeneron.comLinkedIn

Dated updates
83
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
154
Latest SEC filing
Jul 30, 2026

Overview

Regeneron by topic

Latest events

Latest Regeneron events

All Regeneron news →
  1. Earnings
    Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026Regeneron Pharmaceuticals will report its third quarter 2026 financial and operating results on October 30, 2026.
    globenewswire.com
  2. In development
    Paroxysmal Nocturnal Hemoglobinuria Market Forecast Upto 2036: 5 Emerging Therapies Poised to Accelerate Market GrowthRegeneron Pharmaceuticals is developing Pozelimab + Cemdisiran, a potential therapy for paroxysmal nocturnal hemoglobinuria (PNH).
    prnewswire.com
  3. Launch
    Regeneron Pharmaceuticals (REGN) Wins FDA Approval For Pasatru In Adult FOPRegeneron Pharmaceuticals received FDA approval for its drug Pasatru (garetosmab grts) to treat adults with fibrodysplasia ossificans progressiva (FOP).
    finance.yahoo.com
  4. Integration
    Veeva Vault CRM Selected by RegeneronWith Veeva Systems
    prnewswire.com
  5. In development
    Regeneron (REGN) Wins FDA Approval For Pasatru In Ultra-Rare Bone-Forming DiseaseRegeneron Pharmaceuticals plans to begin a paediatric trial for its newly approved FOP drug, Pasatru, later this year.
    londoninsider.co.uk
  6. Investment
    Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business UpdatesRegeneron made a $125 million equity investment and upfront payment into Parabilis Medicines as part of a strategic research collaboration.
    manilatimes.net
  7. In development
    Regeneron Pharmaceuticals Q2 Earnings Call HighlightsWith U.S. Food and Drug Administration · 3 stories
    tradingview.com
  8. Revenue
    Regeneron Reports Second Quarter 2026 Financial and Operating ResultsRegeneron Pharmaceuticals reported a 17% increase in revenues for the second quarter of 2026.
    globenewswire.com
  9. Investment
    FDA to fast-track Regeneron drug facility in Saratoga CountyRegeneron Pharmaceuticals is building a 1 million-square-foot drug development and manufacturing facility in Saratoga Springs, a project expected to cost $2 billion.
    timesunion.com
  10. In development
    Regeneron and CytomX extend cancer therapy partnership to $4bn deal.
    pharmaceutical-business-review.com

Showing 10 of 26 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Regeneron with the Signal API

One POST /v1/companies/enrich call with regeneron.com returns every signal type for Regeneron, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"regeneron.com","limit":20}'

Same industry

Companies related to Regeneron

Regeneron questions

What is the latest news on Regeneron?
On Sep 24, 2026, globenewswire.com reported: Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026. This page tracks 26 news events for Regeneron since Oct 30, 2025, each with a date and a source link.
What is going on with Regeneron?
In the 90 days to Sep 30, 2026, Autobound tracked 9 news events, 1 10-Q filing, 1 8-K filing, 4 hiring snapshots, 42 signals for Regeneron. The newest story is from Sep 24, 2026 (Earnings), reported by globenewswire.com.
What else does Autobound track for Regeneron?
Beyond news and filings, Autobound lists 50+ signals for Regeneron from 7 sources: Glassdoor (15+), Website changes (15+), Patents (12), LinkedIn (4), Podcasts (2), Reddit (1), Web traffic (1). See the Regeneron signals page for the dated list.
Is Regeneron hiring right now?
Yes. As of Sep 29, 2026, Regeneron had 154 open roles, and Research and development had the most with 23.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →